Timeline

Eric Prina
Permanent Researcher
15 Nov 2022
publication

Trifloxystrobin blocks the growth of Theileria parasites and is a promising drug to treat Buparvaquone resistance.

Read more
10 Feb 2022
project

ANR ELATION: Epigenetic subversion in Leishmania macrophage infection

Read more
22 Jun 2020
publication

Dynamic imaging reveals surface exposure of virulent Leishmania amastigotes during pyroptosis of infected macrophages.

Read more
20 May 2020
publication

Infectivity and Drug Susceptibility Profiling of Different Leishmania-Host Cell Combinations.

Read more
20 Feb 2020
publication

SILAC-based quantitative proteomics reveals pleiotropic, phenotypic modulation in primary murine macrophages infected with the protozoan pathogen Leishmania donovani.

Read more
11 Feb 2020
publication

Targeting Macrophage Histone H3 Modification as a Leishmania Strategy to Dampen the NF-κB/NLRP3-Mediated Inflammatory Response.

Read more
01 Jan 2020
publication

Leishmania amazonensis Subverts the Transcription Factor Landscape in Dendritic Cells to Avoid Inflammasome Activation and Stall Maturation.

Read more
24 Jan 2019
publication

Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening.

Read more
16 Jan 2019
project

International Mixed Unit ‘Inflammation and Leishmania infection’ (IMU-InflaLeish): Exploiting host-pathogen interaction for the discovery of novel anti-microbial drug targets and drug candidates.

Read more
16 Jan 2019
project

“Modelling and functional analysis of clonal Evolution in Leishmania – possible role of non-coding RNAs and RNA modification”

Read more
23 Dec 2016
publication

Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth

Read more
22 Sep 2016
publication

Exploration of the imidazo[1,2-b]pyridazine scaffold as a protein kinase inhibitor

Read more
01 May 2016
publication

From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity.

Read more
08 Sep 2015
project

ANR Patho-Methylome – The role of lysine methylation in host-pathogen interactions

Read more
07 Sep 2015
project

FP7 Anti-Parasitic Drug Discovery in Epigenetics (A-ParaDDisE)

Read more
07 Sep 2015
project

FP7 Targeting the Leishmania kinome for the development of novel anti-parasitic strategies (LeishDrug)

Read more
07 Sep 2015
project

ANR TransLeish – Discovery of druggable protein kinases in the protozoan parasite Leishmania donovani using hit compounds identified by phenotypic screening

Read more
07 Sep 2015
project

PTR 539 – A multilevel systems approach to elucidate the host-Leishmania interactome and to identify host targets for anti-leishmanial drug discovery

Read more
07 Sep 2015
project

PTR 496 – Investigating the reciprocal relationship between macrophage inflammasome activity and intracellular Leishmania infection

Read more
11 May 2015
team

Molecular Parasitology and Signaling

Read more
31 Oct 2014
publication

Simultaneous multi-parametric analysis of Leishmania and of its hosting mammal cells: A high content imaging-based method enabling sound drug discovery process

Read more
01 Jul 2014
publication

Probing druggability and biological function of essential proteins in Leishmania combining facilitated null mutant and plasmid shuffle analyses.

Read more
01 Jan 2014
publication

Pharmacological assessment defines Leishmania donovani casein kinase 1 as a drug target and reveals important functions in parasite viability and intracellular infection.

Read more
09 Aug 2012
publication

The crystal structure of the MAP kinase LmaMPK10 from Leishmania major reveals parasite-specific features and regulatory mechanisms.

Read more